A mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth
about
Pyruvate dehydrogenase kinase as a novel therapeutic target in oncologyCancer as a metabolic diseaseThe metabolic advantage of tumor cellsButyrate elicits a metabolic switch in human colon cancer cells by targeting the pyruvate dehydrogenase complexTyrosine phosphorylation of mitochondrial pyruvate dehydrogenase kinase 1 is important for cancer metabolismThe histone deacetylase SIRT6 is a tumor suppressor that controls cancer metabolismAltered expression levels of IDH2 are involved in the development of colon cancerPyruvate dehydrogenase complex activity controls metabolic and malignant phenotype in cancer cellsErk regulation of pyruvate dehydrogenase flux through PDK4 modulates cell proliferationInduction of pyruvate dehydrogenase kinase-3 by hypoxia-inducible factor-1 promotes metabolic switch and drug resistanceStructural basis for inactivation of the human pyruvate dehydrogenase complex by phosphorylation: role of disordered phosphorylation loopsPivotal role of the C-terminal DW-motif in mediating inhibition of pyruvate dehydrogenase kinase 2 by dichloroacetateDistinct structural mechanisms for inhibition of pyruvate dehydrogenase kinase isoforms by AZD7545, dichloroacetate, and radicicolChronic CSE treatment induces the growth of normal oral keratinocytes via PDK2 upregulation, increased glycolysis and HIF1α stabilizationMetabolic targeting of lactate efflux by malignant glioma inhibits invasiveness and induces necrosis: an in vivo studyTargeting cellular metabolism to improve cancer therapeuticsRedox-directed cancer therapeutics: molecular mechanisms and opportunitiesHexokinase-2 bound to mitochondria: cancer's stygian link to the "Warburg Effect" and a pivotal target for effective therapyA new view of carcinogenesis and an alternative approach to cancer therapyDichloroacetate (DCA) as a potential metabolic-targeting therapy for cancerHypoxia-inducible factor 1 and dysregulated c-Myc cooperatively induce vascular endothelial growth factor and metabolic switches hexokinase 2 and pyruvate dehydrogenase kinase 1Mitochondria, cholesterol and cancer cell metabolismThe sweet trap in tumors: aerobic glycolysis and potential targets for therapyIntegration of Mitochondrial Targeting for Molecular Cancer TherapeuticsRedox biology in pulmonary arterial hypertension (2013 Grover Conference Series)Targeting Tumor Metabolism for Cancer Treatment: Is Pyruvate Dehydrogenase Kinases (PDKs) a Viable Anticancer Target?Mitochondrial Dysfunction and Disturbed Coherence: Gate to Cancer.Pyruvate Dehydrogenase Kinases: Therapeutic Targets for Diabetes and CancersCancer metabolic reprogramming: importance, main features, and potentials for precise targeted anti-cancer therapiesRegulation of mitochondrial function by voltage dependent anion channels in ethanol metabolism and the Warburg effectWhat is good for the circulation also lessens cancer riskInterdisciplinary networks for the treatment of childhood pulmonary vascular disease: what pulmonary hypertension doctors can learn from pediatric oncologistsRestoration of mitochondria function as a target for cancer therapyMetabolic reprogramming and metabolic dependency in T cellsApplication of metabolomics in drug resistant breast cancer researchThe diverse role of the PPARγ coactivator 1 family of transcriptional coactivators in cancerNovel therapeutic targets of tumor metabolismIon channels and apoptosis in cancerVoltage-gated ion channels in cancer cell proliferationRedox activation of metal-based prodrugs as a strategy for drug delivery
P2860
Q21129303-79D4265F-2E01-4610-A585-5557B1466933Q21245061-ECFAEF6A-9354-4E22-BD18-4C3564512335Q21245765-A579A99A-C8B6-457C-A090-687C567B9197Q24296447-4BE1B16B-8CAB-410A-A253-79340B3AE64DQ24300524-88CC2243-F230-48E8-BE36-C3132A8EECC5Q24305332-6F97813F-093D-41A8-B32A-45FF7A32BB99Q24305486-E10D1E0C-3530-4C8C-B5A9-BE32332B03A3Q24320179-33236132-BFB0-400D-9B49-FD3C6435646FQ24323390-1D1A5F0A-6D2A-4466-B212-C1F6481AB35EQ24329133-9105AF27-716B-4206-AC53-58729B48928DQ24329273-DD9DE5E5-3E4A-4D52-B90A-10F60948DB94Q24336339-5BC3D5EA-E730-41CD-87AF-F64731E1E5A0Q24336876-EB098232-D692-4944-84F0-A0F6DD43B81BQ24338864-E1060E58-9172-42EA-BE7D-A77A8ECFBCB5Q24594748-D8340CED-BBDC-458F-92BD-ECCCC84E5A47Q24596727-23389689-626C-435E-8BD3-2147E92AEF5DQ24645584-7185DD38-A047-4DD8-831E-5D4DC96E8195Q24646296-698F78C0-64B3-4EE1-9672-B07BABDBB7EBQ24650249-508B6BBE-4B33-4246-851D-F2C4D6FA2C1BQ24652941-ABFBAE72-FA2C-422D-86A4-AE0B77149922Q24681460-CBC657CA-FF35-4217-83B7-05105C97A1E2Q26741708-4A6A6714-D1D5-4AEB-B0BD-EB1D4F182F31Q26766079-D02EDA58-4524-4B5C-9C7B-957D74FA8F76Q26771751-10F22748-2A32-46B2-B163-AC0D633E3B14Q26772286-0E7A10B4-1EEA-49A3-9A73-DDFB152BB2BDQ26774957-230A617D-B68B-4193-8F29-3BE4C4A94079Q26782068-EC00D414-0EEA-4320-AFD8-421A92CC11A2Q26822845-4D10DFFA-B505-47FD-B736-F3046B11E631Q26823118-5573D32E-0092-4AED-B406-DFABE9E0F1B8Q26827829-E32DFE5E-7444-4825-9B19-7F04CD46009CQ26859261-F6B4F4A0-1AA7-4C0F-969B-1FE4C69D2E38Q26860314-9A4A75A4-4AF1-4894-A6C7-E0117717E5CEQ26864167-06B30C79-2E06-451E-B0FA-BF330C60CEE4Q26864319-1F19B075-6FB7-4D40-BCCA-7538DC084180Q26866291-6317BD7C-9E6B-42A0-B247-54FF5DB0A6E1Q26997789-44313E06-931B-4543-B377-A0334E5DD5B6Q27005930-833D2CB4-AEE9-4A0D-97E2-E02D0023803DQ27005947-BB58C475-66D2-45B4-9603-61674CF898DAQ27010511-C7DE68F5-55E9-4A46-AB8D-13F2C63F748BQ27025736-07B25B1C-031C-4D0F-874B-839A34720176
P2860
A mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth
description
2007 nî lūn-bûn
@nan
2007 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
A mitochondria-K+ channel axis ...... sis and inhibits cancer growth
@ast
A mitochondria-K+ channel axis ...... sis and inhibits cancer growth
@en
A mitochondria-K+ channel axis ...... sis and inhibits cancer growth
@nl
type
label
A mitochondria-K+ channel axis ...... sis and inhibits cancer growth
@ast
A mitochondria-K+ channel axis ...... sis and inhibits cancer growth
@en
A mitochondria-K+ channel axis ...... sis and inhibits cancer growth
@nl
prefLabel
A mitochondria-K+ channel axis ...... sis and inhibits cancer growth
@ast
A mitochondria-K+ channel axis ...... sis and inhibits cancer growth
@en
A mitochondria-K+ channel axis ...... sis and inhibits cancer growth
@nl
P2093
P50
P3181
P1433
P1476
A mitochondria-K+ channel axis ...... sis and inhibits cancer growth
@en
P2093
Alois Haromy
Bernard Thebaud
Christian Beaulieu
Christopher T Lee
Evangelos D Michelakis
Gary D Lopaschuk
Gwyneth Harry
Joan Allalunis-Turner
Kyoko Hashimoto
Lakshmi Puttagunta
P3181
P356
10.1016/J.CCR.2006.10.020
P407
P577
2007-01-01T00:00:00Z